nCounter analysis of mRNAs associated with muscle invasive urothelial bladder carcinoma (MIBC) using a Nanostring custom assay
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Gene profiling analysis to evaluate pre- and post-immune checkpoint therapy with tremelimumab (anti-CTLA-4) plus durvalumab (anti-PD-L1) as neoadjuvant treatment prior to radical cystectomy in MICB were analyzed using customized 749- gene Nanostring panel 21 pretreatment and 13 tremelimumab (anti-CTLA-4) plus durvalumab (anti-PD-L1) treated patient samples were analyzed
创建时间：
2022-11-03
